Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen

Rare Tumors

关键词: Basal cell adenocarcinoma;    estrogen receptor;    tamoxifen;    supraglottic larynx;   

DOI  :  10.4081/rt.2011.e55

来源: DOAJ

【 摘 要 】

At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age of 93, during a routine examination, the patient was found to have palpable adenopathy and underwent a fine needle aspiration in June 2010. Pathology revealed similar histologic characteristics of her 2001 BCAC diagnosis, and further IHC stains revealed positive estrogen receptor staining.

【 授权许可】

Unknown